IMB's Dr Larisa Labzin has won the NHMRC Frank Fenner Award for having the top-ranked early career research fellowship in 2016.

Professor Peter Koopman speaks about his research into CRISPR and the possibilities it could offer to future generations, as well as those suffering from genetic conditions right now.

A discovery by University of Queensland researchers about the evolution of a tiny fish could have implications for sufferers of muscle diseases such as muscular dystrophy.

IMB PhD student Andrew White will network with Nobel Prize winners at the 67th Lindau Nobel Laureate Meeting later this month.

Professor Yang, a statistical genomics researcher, received the Senior Researcher Award at the Queensland ASMR Gala Dinner in Brisbane on 2 June during ASMR Medical Research Week.

UQ IMB spinout company, Protagonist Therapeutics Inc., recently announced that it has initiated a Phase 1 clinical study and entered into a $1 billion worldwide agreement with a global pharmaceutical company.

In the world’s largest study into the genetic causes of endometriosis, Institute for Molecular Bioscience researchers have helped identify five new gene regions linked to the disease.

A new gene behind a rare form of inherited childhood kidney disease has been identified by a global research team. UQ IMB researchers were part of the team that made the discovery that will improve genetic testing and could provide clues for future treatments for autosomal recessive polycystic kidney disease (ARPKD).

Advances in life science research provide critical knowledge across a wide range of biological fields, informing everything from our fundamental understanding of evolutionary biology to remarkable progress in personalised medicine. In order to ensure the security and global accessibility of molecular data, a concerted effort must be toward shared responsibility for the support and maintenance of core data resources.